Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. Author manuscript; available in PMC: 2019 Apr 24.

Published in final edited form as: JCSM Rapid Commun. 2019 Jan-Jun;2(1):e00075.

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. http://creativecommons.org/licenses/by/4.0/

PMC Copyright notice

Figure 3. — In vivo treatment with carboplatin causes skeletal muscle dysfunction.

(a) Forelimb grip strength in Non-tumor + vehicle, MDA-MB-321 + vehicle, Non-tumor + carboplatin, and MDA-MB-231 + carboplatin groups, (b) Whole muscle contractility of the EDL muscle (specific force) from Non-tumor + vehicle, MDA-MB-321 + vehicle, Non-tumor + carboplatin, and MDA-MB-231 + carboplatin groups, (a & b) Two-way ANOVA with Tukey’s post-hoc test for multiple comparisons (n=10 per group), **p<0.01, ****p<0.0001 compared to Non-tumor + vehicle.